Delivery Order 36F79723D010E-36C26123N0588
Award Date 5/12/23
Potential Completion Date 7/11/23
Potential Value $75K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Palo Alto, CA 94304, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amylyx Pharmaceuticals Inc., doing business as Amylyx, is for the delivery of RELYVRIO Sodium, an FDA-approved treatment for amyotrophic lateral sclerosis (ALS). The $42,334.56 firm-fixed-price delivery order was issued by the Veterans Integrated Service Network 21 (VISN 21), a division of the Department of Veterans Affairs (VA). The contract has no set-aside designation and is intended to supply RELYVRIO to VA medical facilities in the western United States....
- <p>The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 (VA-VHA) awarded a $284,978.20 firm fixed price delivery order contract to Amylyx Pharmaceuticals Inc., doing business as Amylyx, of Cambridge, Massachusetts. The contract term is from June 2, 2023 through September 30, 2023 for the provision of RELYVRIO, a pharmaceutical product, to the VA-VHA. No subcontractors were identified.</p>
- Amylyx Pharmaceuticals Inc., doing business as Amylyx, has been awarded a $74,879.68 firm fixed price delivery order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 (VA VHA VISN 21) to provide RELYVRIO. The prime contractor Amylyx will deliver the products from its place of performance in Cambridge, Massachusetts between August 10, 2023 and September 30, 2023 to support the VA VHA VISN 21's healthcare programs for veterans. No major...
- Amylyx Pharmaceuticals Inc., doing business as Amylyx, has been awarded a $10,583.64 firm fixed price delivery order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 (VA VHA VISN 21) to provide RELYVRIO. The prime contractor Amylyx will deliver the products from its place of performance in Cambridge, Massachusetts between July 27, 2023 and September 27, 2023. No major subcontractors or set aside designations were indicated. This delivery...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a $74,879.68 firm fixed price delivery order contract to Amylyx Pharmaceuticals Inc., doing business as Amylyx, of Cambridge, Massachusetts. The contract calls for Amylyx to provide sodium phenylbutyrate and taurursodiol powder packets for oral administration to support VHA programs. The place of performance is Amylyx's headquarters in Cambridge. The period of performance is from...
- This federal contract award is for "EMERGENCY LYMYRZ" and was issued by the Veterans Integrated Service Network 9 (VISN 9), a civilian agency. The contract was awarded to Avadel CNS Pharmaceuticals, LLC, a for-profit, foreign-owned organization, on September 22, 2025 as a Firm Fixed Price Delivery Order with a ceiling value of $11,197.82 and a completion date of September 30, 2025. The contract is not set aside and is under the Pharmaceuticals and Drugs Federal Supply Schedule...
- This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Acorda Therapeutics, Inc., a biotechnology company specializing in neurological therapies. The $861,948.00 contract is for the supply of DALFAMPRIDINE, a medication used to treat Parkinson's disease symptoms. The contract is placed under Acorda's Federal Supply Schedule (FSS) contract with the VA, which is valued at over $16.3 million and allows the VA to procure Acorda's pharmaceutical...
- This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs Veterans Health Administration to Anovorx Distribution LLC, a small business for-profit limited liability company, to provide the medication Firdapse (Amifampridine). The contract has a potential value of $151,359.02 and a completion date of September 19, 2019. Anovorx Distribution LLC has provided various specialty pharmaceutical products to the VA and Department of the Army Medical Command...
- This is a firm fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Acorda Therapeutics, Inc., a biotechnology company specializing in neurological therapies. The $478,860.00 contract is for the provision of DALFAMPRIDINE, which is likely a pharmaceutical product used to treat Parkinson's disease or multiple sclerosis. The delivery order was issued under Acorda's existing Federal Supply Schedule (FSS) contract with the VA, valued at over $16.3 million, for the...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 1 (VISN 1), awarded a firm fixed-price purchase order to Trillamed LLC for AMYVID on December 11, 2025, with a ceiling value of $926,720. AMYVID is a diagnostic imaging agent used in positron emission tomography (PET) scans to detect amyloid plaques in the brain, supporting the diagnosis of Alzheimer's disease and related cognitive conditions. The contract, which will be performed in Boston, Massachusetts, carries an...